RYTM — RHYTHM PHARMACEUTICALS INC

Ownership history in Quantbot Technologies LP  ·  6 quarters on record

This page tracks every 13F SEC filing in which Quantbot Technologies LP reported a position in RHYTHM PHARMACEUTICALS INC (RYTM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2023 Q4)
Avg. % of fund
0.01%
First filed
2018 Q2
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 4,981 +1,381 +38.4% 0.01% $503K $100.99
2024 Q1 REDUCED 3,600 -4,400 -55.0% 0.01% $156K $43.33
2023 Q4 ADDED 8,000 +5,462 +215.2% 0.02% $368K $45.97
2022 Q1 ADDED 2,538 +1,075 +73.5% 0.00% $29K $11.52
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RYTM price (monthly, adj. close)

Other funds also holding RYTM

As of 2025 Q4 — sorted by position size

Checkpoint Capital L.P. 33.18% NEA Management Company, LLC 3Y 7Y 15.88% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 7.31% PERCEPTIVE ADVISORS LLC 3Y 7Y 4.86% Nan Fung Group Holdings Ltd 3Y 4.71% Opaleye Management Inc. 3Y 7Y 4.66% Sio Capital Management, LLC 3Y 7Y 4.47% Rock Springs Capital Management LP 3Y 7Y 3.81% BAKER BROS. ADVISORS LP 3Y 7Y 3.51% Integral Health Asset Management, LLC 3Y 2.52%
← Back to Quantbot Technologies LP Holdings